Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 27;19(12):3765.
doi: 10.3390/ijms19123765.

Apoptosis Induction of Agave lechuguilla Torrey Extract on Human Lung Adenocarcinoma Cells (SK-LU-1)

Affiliations

Apoptosis Induction of Agave lechuguilla Torrey Extract on Human Lung Adenocarcinoma Cells (SK-LU-1)

Luis Alberto Anguiano-Sevilla et al. Int J Mol Sci. .

Abstract

In this study, an ethanol extract of Agave lechuguilla was evaluated against six carcinogenic cell lines (HCT-15, MCF-7, PC-3, U-251, SK-LU-1 and K-562) with an inhibition of 75.7 ± 2.3% against the SK-LU-1 line. Based on the previous result, the extract was hydrolyzed and fractionated, to which the IC50 was determined; the cell line was more sensitive to the fractionated extract with an IC50 6.96 ± 0.15 µg/mL. Characterization by mass spectrometry showed the presence of kaempferol, quercetin and a flavonoid dimer formed by afzelechin-4β-8-quercetin, according to the generated fragmentation pattern. The fractionated extract presented cell death by apoptosis with 39.8% at 24 h. Molecular docking was performed with the molecules found to try to describe cell death by apoptosis through death receptors such as FasCD95, TNF-R1, DR4/5 and blocking signaling on the EGFR and K-Ras MAPK/ERK pathway, as well as through the intrinsic pathway activating tBID, which promotes the amplification of the apoptotic signal due to the activation of caspase-3, and consequently caspase-7. In addition to the activation of the IIb complex associated with cell death due to necroptosis.

Keywords: Agave lechuguilla; apoptosis; cytotoxic activity; mass spectrometry; molecular docking.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structure of flavonoids and biflavonoid dimer with numbers associated to in silico results. (a) Kaempferol 287 g/mol (b) Quercetin 302 g/mol, and (c) Biflavonoid (afzelequin 4β-8 quercetin), 574 g/mol.
Figure 1
Figure 1
Structure of flavonoids and biflavonoid dimer with numbers associated to in silico results. (a) Kaempferol 287 g/mol (b) Quercetin 302 g/mol, and (c) Biflavonoid (afzelequin 4β-8 quercetin), 574 g/mol.
Figure 2
Figure 2
Translocation of phosphatidylserine by flow cytometry (Annexin V-FITC/7-AAD staining). Representative plots of SK-LU-1 cells cultured in the presence fractioned extract of A. lechuguilla with an IC50 = 6.96 μg/mL, are shown (total apoptosis-time of exposure).
Figure 3
Figure 3
Binds of biflavonoid, kaempferol and quercetin with death receptor. The box indicates the binding region. (a) Biflavonoid binds to TNF-R1, (b) Biflavonoid binds to DR4, (c) Kaempferol binds to Fas/CD95, (d) Kaempferol binds to DR5 (e) Quercetin binds to TNF-R1, (f) Quercetin binds to DR4, (g) Biflavonoid binds to EGFR, and (h) Biflavonoid binds to K-Ras.
Figure 3
Figure 3
Binds of biflavonoid, kaempferol and quercetin with death receptor. The box indicates the binding region. (a) Biflavonoid binds to TNF-R1, (b) Biflavonoid binds to DR4, (c) Kaempferol binds to Fas/CD95, (d) Kaempferol binds to DR5 (e) Quercetin binds to TNF-R1, (f) Quercetin binds to DR4, (g) Biflavonoid binds to EGFR, and (h) Biflavonoid binds to K-Ras.

Similar articles

Cited by

References

    1. Zhang Y.-J., Gan R.-Y., Li S., Zhou Y., Li A.-N., Xu D.-P., Li H.-B., Zhang Y.-J., Gan R.-Y., Li S., et al. Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases. Molecules. 2015;20:21138–21156. doi: 10.3390/molecules201219753. - DOI - PMC - PubMed
    1. Global Cancer Observatory. [(accessed on 26 September 2018)]; Available online: http://gco.iarc.fr/
    1. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer. 2003;3:11–22. doi: 10.1038/nrc969. - DOI - PubMed
    1. Gazdar A.F., Girard L., Lockwood W.W., Lam W.L., Minna J.D. Lung cancer cell lines as tools for biomedical discovery and research. J. Natl. Cancer Inst. 2010;102:1310–1321. doi: 10.1093/jnci/djq279. - DOI - PMC - PubMed
    1. Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never smokers—A different disease. Nat. Rev. Cancer. 2007;7:778–790. doi: 10.1038/nrc2190. - DOI - PubMed

MeSH terms